Inogen strengthens leadership team with appointment of new general counsel and executive vice president, business development

Goleta, calif.--(business wire)--inogen, inc. (nasdaq: ingn), a medical technology company offering innovative respiratory products for use in the homecare setting, today announced the appointment of kevin p. smith as general counsel and executive vice president, business development, effective july 22, 2024. mr. smith joins inogen from sirtex medical, where he served as general counsel and executive vice president, business development, since 2018. mr. smith brings nearly thirty years of exper.
INGN Ratings Summary
INGN Quant Ranking